Collaborators & partnerships
Our research is strongly collaborative and is further strengthened by the ‘bench to bedside' approach facilitated by the close physical proximity of two medical research institutes and the Monash University Central Clinical School and School of Public Health and Preventive Medicine.
Monash Partners Academic Health Science Centre
Alfred Health is a founding partner in Monash Partners Academic Health Science Centre, a collaboration between eight major health care, research and education institutions. Monash Partners was one of four Australian health centres recognised by the National Health and Medical Research Council (NHMRC) in 2015 as being among the world’s best for using medical research to improve patient care. The other partners are Monash University, Baker Heart & Diabetes Institute, Burnet Institute, Monash Health, Cabrini Health, Epworth Healthcare and the Hudson Institute of Medical Research,
Alfred Medical Research and Education Precinct (AMREP)
Alfred Health is a founding partner in the Alfred Medical Research and Education Precinct (AMREP) with Monash University, Baker Heart & Diabetes Institute, Burnet Institute, La Trobe University and Deakin University. This collaboration, on The Alfred hospital campus, links health and medical research with education and healthcare delivery providing the ideal environment for rapid translation of research findings into improved health policy and clinical practice. The benefits of this partnership include valuable collaborations and shared research platforms.
Other partnerships
Alfred Health is a also a partner in the Monash Comprehensive Cancer Consortium (MCCC) and the Southern Melbourne Integrated Cancer Centre (SMICS).
Latest news
The Alfred joins global heart trial
The Alfred is the first Australian hospital to take part in a global trial that could eliminate the need for open heart surgery in some patients suffering a common heart valve disease.
New research reveals dangers of cupping
Burns specialists at The Alfred have highlighted the risks associated with the alternative medicine practice, known as cupping.
Peanut allergy treatment to ‘reset’ the immune system
Human clinical trials of a world-first peanut allergy treatment will begin in Melbourne next month, with researchers focussing on the molecular parts of the potent nut allergen that are needed to build tolerance, while removing the risk of a severe reaction.